Literature DB >> 9199462

Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.

D M Williams1, B G Grubbs, E Pack, K Kelly, R G Rank.   

Abstract

A murine model of pneumonia due to the mouse pneumonitis agent (MoPn [murine Chlamydia trachomatis]) in mice deficient in CD4+ T-cell function (major histocompatibility complex [MHC] class II function [class II-/-], CD8+ T-cell function (beta2-microglobulin deficient, MHC class I deficient [Beta2m-/-]), B-cell function (C57BL/10J-Igh(tm1Cgn) [Igh-/-]), and gamma interferon (IFN-gamma) (C57BL/6-Ifg(tm1) [Ifg-/-]) or interleukin-4 (C57BL/6J(tm1Cgn29) [IL4-/-]) production was employed to determine if each of these mechanisms was critical to resistance against reinfection by C. trachomatis or if alternate compensatory mechanisms existed in their absence which could potentially be exploited in vaccine development. Resistance to reinfection with MoPn was heavily dependent on CD4+ T cells. CD4 T-cell-deficient MHC class II-/- mice were very susceptible to reinfection with MoPn, showing the critical importance of this cell to resistance. These mice lacked antibody production but did produce IFN-gamma, apparently by mechanisms involving NK and CD8+ T cells. Neutralization of IFN-gamma in these mice led to a borderline increase in susceptibility, showing a possible role (albeit small) of this cytokine in this setting. Tumor necrosis factor alpha (TNF-alpha) was also present at increased levels in these mice. Igh-/- B-cell-deficient mice which produce no antibody to MoPn were only modestly more susceptible to reinfection than immunized B-cell-intact controls, showing that antibody, including lung immunoglobulin A, is not an absolute requirement for relatively successful host defense in this setting. Levels of lung IFN-gamma and TNF-alpha were elevated in Igh-/- mice compared to those in controls. IL-4-/- mice (deficient in Th2 function) could develop normal resistance to reinfection with MoPn. Conversely, normal mice rendered partially IFN-gamma deficient by antibody depletion were somewhat impaired in their ability to develop acquired immunity to MoPn, again indicating a role for this cytokine in host defense against rechallenge. Of most importance, however, congenitally IFN-gamma-deficient Ifg-/- mice (which have elevated levels of other cytokines, including TNF-alpha and granulocyte-macrophage colony-stimulating factor) are paradoxically more resistant to MoPn rechallenge than controls, showing that IFN-gamma is not an absolute requirement for acquired resistance and implying the presence of very effective compensatory host defense mechanism(s). In vivo depletion of TNF-alpha significantly increased MoPn levels in the lungs in these mice. Thus, resistance to reinfection in this model is flexible and multifactorial and is heavily dependent on CD4+ T cells, with a probable role for IFN-gamma and TNF-alpha and a possible modest role for Th1-dependent antibody. Since IFN-gamma was dispensable in host defense, the highly effective mechanism or mechanisms which can compensate for its absence (which include TNF-alpha) deserve further study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199462      PMCID: PMC175404          DOI: 10.1128/iai.65.7.2876-2882.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Generation of gamma interferon responses in murine Peyer's patches following oral immunization.

Authors:  A George
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Chlamydia trachomatis pneumonia in the immune, athymic and normal BALB mouse.

Authors:  J J Coalson; V T Winter; L B Bass; J Schachter; B G Grubbs; D M Williams
Journal:  Br J Exp Pathol       Date:  1987-06

3.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; B Grubbs
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

5.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.

Authors:  D M Williams; G I Byrne; B Grubbs; T J Marshal; J Schachter
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice.

Authors:  D M Williams; B Grubbs; J Schachter
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

Authors:  D M Williams; J Schachter; D J Drutz; C V Sumaya
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

9.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.

Authors:  K H Ramsey; L S Soderberg; R G Rank
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination.

Authors:  B H Koller; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more
  38 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.

Authors:  Cathi Murphey; Ashlesh K Murthy; Patricia A Meier; M Neal Guentzel; Guangming Zhong; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2006-11-20       Impact factor: 4.868

4.  Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.

Authors:  C Wang; J Tang; P A Crowley-Nowick; C M Wilson; R A Kaslow; W M Geisler
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

5.  Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.

Authors:  Catarina V Nogueira; Xuqing Zhang; Nicholas Giovannone; Erica L Sennott; Michael N Starnbach
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

6.  Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein.

Authors:  D Vanrompay; E Cox; G Volckaert; B Goddeeris
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.

Authors:  J C Goodall; H Beacock-Sharp; K H Deane; J S Gaston
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

8.  A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection.

Authors:  D M Williams; B G Grubbs; T Darville; K Kelly; R G Rank
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Reinfection with Chlamydophila abortus by uterine and indirect cohort routes reduces fertility in cattle preexposed to Chlamydophila.

Authors:  Fred J DeGraves; TeaYoun Kim; JunBae Jee; Tobias Schlapp; Hans-Robert Hehnen; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  B cells are essential for moderating the inflammatory response and controlling bacterial multiplication in a mouse model of vaccination against Chlamydophila abortus infection.

Authors:  Antonio J Buendía; Nieves Ortega; María R Caro; Laura Del Río; María C Gallego; Joaquín Sánchez; Jose A Navarro; Francisco Cuello; Jesús Salinas
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.